Category

Investing

Category

Data will support design and planning of first in human clinical trials Preparing for pre-IND meeting with the FDA InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company developing a pipeline of proprietary small-molecule drug candidates for diseases with high unmet medical needs, today announced the successful…